Drug Shortage Report for APO-PREGABALIN

Last updated on 2021-04-26 History
Report ID 137595
Drug Identification Number 02394286
Brand name APO-PREGABALIN
Common or Proper name PREGABALIN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) PREGABALIN
Strength(s) 225MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100 BTL
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-04-12
Estimated end date 2021-04-30
Actual end date 2021-04-23
Shortage status Resolved
Updated date 2021-04-26
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-04-26 French Compare
v5 2021-04-26 English Compare
v4 2021-04-21 French Compare
v3 2021-04-21 English Compare
v2 2021-04-16 French Compare
v1 2021-04-16 English Compare